Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
40,971,724
-
Share change
-
+40,254,597
-
Total reported value
-
$120,062,000
-
Put/Call ratio
-
34%
-
Price per share
-
$2.93
-
Number of holders
-
85
-
Value change
-
+$117,961,261
-
Number of buys
-
84
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q4 2021
As of 31 Dec 2021 Xeris Biopharma Holdings, Inc. - COM (XERS) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,971,724 shares of stock of the company.
Largest 10 holders included CAXTON CORP, Stonepine Capital Management, LLC, VANGUARD GROUP INC, NEA Management Company, LLC, LAZARD ASSET MANAGEMENT LLC, Invesco Ltd., BlackRock Inc., Man Group plc, MORGAN STANLEY, and Redmile Group, LLC.
This table shows 85 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.